2 Ha’eshel St.
38900 Caesarea
Israel
P.O. Box 35 79
38900 Caesarea
Phone: +972 4 6177000
Fax: +972 4 6177014
http://www.itamar-medical.com
info@itamar-medical.com
OEM
Company Figures
Number of employees 50-99
Sales volume 10-49 Mio US $
Export content > 75%
Year of foundation 1997
Area of business Electronical Equipment / Medical Technology
Diagnostics
Company Profile
About Us
tamar Medical Ltd., established in 1997, is a public medical signal company engaged in the development of a proprietary non-invasive window to the cardiovascular system and the autonomic nervous system – the PAT™ (Peripheral Arterial Tone) signal.
Using advanced Digital Signal Processing algorithms to apply PAT in numerous clinical applications, Itamar Medical’s researchers developed new ways to make practical use of this new signal. To date, clinical trials and testing are being conducted to potentially apply the PAT Signal in screening, diagnosis and follow-up in various clinical conditions, such as:
Endothelial Dysfunction
Coronary Artery Disease (CAD)
Chest pain evaluation (Acute Coronary Syndrome)
Congestive Heart Failure (CHF)
Obstructive Sleep Apnea (OSA)
Cheyne-Stokes Breathing Patterns (CSB)
Exercise Stress Test
Biofeedback
Beat-to-beat Blood Pressure monitoring
PAT based products, can provide an early-stage detection of disease, facilitate patient follow-up, and help to improve patient care while reducing the overall cost of healthcare.
Itamar Medical is currently focusing on 2 main PAT Technology-based products which have been cleared for sale in the USA, Canada & Europe:
Endo-PAT2000 – non-invasive assesment of endothelial function.
Watch-PAT100 – an innovative unattended home care diagnostic device for the detection of sleep related breathing disorders and REM/nREM/wake sleep stages.
The PAT signal is a measure of pulsatile arterial volume changes at the fingertip. The PAT signal is acquired by Itamar’s unique non-invasive PAT finger probes. This technology can be applied to almost any clinical setting. Itamar Medical’s PAT based devices strategically position the company to meet the diagnostic and consulting needs of busy medical centers and practices.
Itamar Medical is committed to delivering the highest levels of quality and customer satisfaction. At Itamar Medical quality is a priority requiring management and employees at all levels to continuously strive for excellence and improvement.
Itamar Medical is a public corporation (Tel Aviv Stock Exchange symbol: ITMR) headquartered in Caesarea, Israel. Investors include Medtronic Inc., the world’s largest medical technology company.
Our Mission
Itamar Medical is dedicated to the research, development and commercialization of a wide range of medical products and services based on its proprietary PAT (Peripheral Arterial Tone) Signal and innovative non-invasive measurement technologies.
Quality Policy
It is the policy of Itamar Medical to provide reliable, safe and effective products and services to our customers through a commitment to quality that is understood, implemented and maintained at all levels of the organization.